Search Results

There are 4990 results for: content related to: Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open-label study

  1. You have free access to this content
    Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents

    British Journal of Pharmacology

    Volume 156, Issue 2, January 2009, Pages: 226–236, Daniel Scherer, David Hassel, Ramona Bloehs, Edgar Zitron, Katharina Von Löwenstern, Claudia Seyler, Dierk Thomas, Franziska Konrad, Heiner F. Bürgers, Gunnar Seemann, Wolfgang Rottbauer, Hugo A. Katus, Christoph A. Karle and Eberhard P. Scholz

    Article first published online : 19 JAN 2009, DOI: 10.1111/j.1476-5381.2008.00018.x

  2. Subchronic administration of atomoxetine causes an enduring reduction in context-induced relapse to cocaine seeking without affecting impulsive decision making

    Addiction Biology

    Nienke Broos, Rhianne Loonstra, Yvar van Mourik, Dustin Schetters, Anton N. M. Schoffelmeer, Tommy Pattij and Taco J. De Vries

    Article first published online : 23 JUL 2014, DOI: 10.1111/adb.12168

  3. You have free access to this content
    Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations

    British Journal of Pharmacology

    Volume 160, Issue 2, May 2010, Pages: 283–291, Andrea G Ludolph, Patrick T Udvardi, Ulrike Schaz, Carolin Henes, Oliver Adolph, Henry U Weigt, Joerg M Fegert, Tobias M Boeckers and Karl J Föhr

    Article first published online : 2 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00707.x

  4. Pharmacokinetics, Safety, and Tolerability of Atomoxetine and Effect of CYP2D6*10/*10 Genotype in Healthy Japanese Men

    The Journal of Clinical Pharmacology

    Volume 52, Issue 3, March 2012, Pages: 388–403, Dr A. Matsui, Dr J. Azuma, Dr J. W. Witcher, Ms A. J. Long, Dr J.-M. Sauer, Dr B. P. Smith, Dr K. A. DeSante, Dr H. A. Read, Dr M. Takahashi and Dr M. Nakano

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270011398657

  5. Targeting presynaptic norepinephrine transporter in brown adipose tissue: A novel imaging approach and potential treatment for diabetes and obesity

    Synapse

    Volume 67, Issue 2, February 2013, Pages: 79–93, M. Reza Mirbolooki, Cristian C. Constantinescu, Min-Liang Pan and Jogeshwar Mukherjee

    Article first published online : 8 NOV 2012, DOI: 10.1002/syn.21617

  6. You have free access to this content
    Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers

    British Journal of Clinical Pharmacology

    Volume 75, Issue 2, February 2013, Pages: 549–564, Corina Loghin, Harry Haber, Charles M. Beasley Jr, Prajakti A. Kothare, Lynnette Kauffman, John April, Ling Jin, Albert J. Allen and Malcolm I. Mitchell

    Article first published online : 10 JAN 2013, DOI: 10.1111/j.1365-2125.2012.04382.x

  7. Hemodynamic Effects of Acute Administration of Atomoxetine and Methylphenidate

    The Journal of Clinical Pharmacology

    Volume 45, Issue 7, July 2005, Pages: 851–855, Dr Ronan P. Kelly, Dr Kwee Poo Yeo, Dr Choo-Hua Teng, Dr Brian P. Smith, Dr Stephen Lowe, Dr Danny Soon, Dr Holly A. Read and Dr Stephen D. Wise

    Article first published online : 25 MAR 2013, DOI: 10.1177/0091270005276737

  8. Long-term safety and tolerability of atomoxetine in Japanese adults with attention deficit hyperactivity disorder

    Asia-Pacific Psychiatry

    Volume 6, Issue 3, September 2014, Pages: 292–301, Yuko Hirata, Taro Goto, Yasushi Takita, Paula T Trzepacz, Albert J Allen, Hironobu Ichikawa and Michihiro Takahashi

    Article first published online : 25 DEC 2013, DOI: 10.1111/appy.12119

  9. Atomoxetine, a Novel Treatment for Attention-Deficit—Hyperactivity Disorder

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 8, August 2004, Pages: 1020–1036, Dr. Alisa K. Christman, Dr. Joli D. Fermo and Dr. John S. Markowitz

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.24.11.1020.36146

  10. A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 4, April 2013, Pages: 386–393, Andrew T. McAfee, Joan Landon, Meghan Jones, Mark E. Bangs, Nayan Acharya, Ken Hornbuckle and Judy Wong

    Article first published online : 26 DEC 2012, DOI: 10.1002/pds.3390

  11. A liquid chromatography/tandem mass spectrometry assay for the analysis of atomoxetine in human plasma and in vitro cellular samples

    Biomedical Chromatography

    Volume 26, Issue 11, November 2012, Pages: 1364–1370, David I. Appel, Bryan Brinda, John S. Markowitz, Jeffrey H. Newcorn and Hao-Jie Zhu

    Article first published online : 25 JAN 2012, DOI: 10.1002/bmc.2706

  12. You have free access to this content
    A Modeled Economic Evaluation Comparing Atomoxetine with Stimulant Therapy in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

    Value in Health

    Volume 11, Issue 3, May/June 2008, Pages: 376–388, Suzi Cottrell, Dominic Tilden, Paul Robinson, Jay Bae, Jorge Arellano, Eric Edgell, Mike Aristides and Kristina S. Boye

    Article first published online : 4 SEP 2007, DOI: 10.1111/j.1524-4733.2007.00256.x

  13. Kinetic modeling and occupancy measures of the norepinephrine transporters in baboons using single photon emission computed tomography with 123I-INER

    Synapse

    Volume 67, Issue 1, January 2013, Pages: 30–41, Adriana Alexandre Dos Santos Tavares, Olivier Barret, Jeffery Batis, David Alagille, Andrei Koren, Caroline Papin, Greg Kudej, Katie Nice, Jeffrey H. Kordower, Kelly P. Cosgrove, Tracy Kloczynski, Eric Brenner, John Seibyl and Gilles Tamagnan

    Article first published online : 31 OCT 2012, DOI: 10.1002/syn.21613

  14. Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder

    Asia-Pacific Psychiatry

    Volume 6, Issue 4, December 2014, Pages: 386–396, Soyoung Irene Lee, Dong-Ho Song, Dong Won Shin, Ji Hoon Kim, Young Sik Lee, Jun-Won Hwang, Tae Won Park, Ki-Hwan Yook, Jong Il Lee, Geon Ho Bahn, Yuko Hirata, Taro Goto, Yasushi Takita, Michihiro Takahashi, Sanghoon Lee and Tamás Treuer

    Article first published online : 27 OCT 2014, DOI: 10.1111/appy.12160

  15. Effect of Potent CYP2D6 Inhibition by Paroxetine on Atomoxetine Pharmacokinetics

    The Journal of Clinical Pharmacology

    Volume 42, Issue 11, November 2002, Pages: 1219–1227, Dr. Donna J. Belle, C. Steven Ernest, John-Michael Sauer, Brian P. Smith, Holly R. Thomasson and Jennifer W. Witcher

    Article first published online : 8 MAR 2013, DOI: 10.1177/009127002762491307

  16. Safety of non-therapeutic atomoxetine exposures—a national poison data system study

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 5, September 2013, Pages: 471–476, Andrew A. Monte, Alessandro Ceschi and Michael Bodmer

    Article first published online : 17 JUL 2013, DOI: 10.1002/hup.2334

  17. You have free access to this content
    Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice

    Journal of Neurochemistry

    Volume 114, Issue 1, July 2010, Pages: 259–270, Ken Koda, Yukio Ago, Yana Cong, Yuki Kita, Kazuhiro Takuma and Toshio Matsuda

    Article first published online : 16 APR 2010, DOI: 10.1111/j.1471-4159.2010.06750.x

  18. Postmortem Tissue Distribution of Atomoxetine Following Fatal and Nonfatal Doses—Three Case Reports

    Journal of Forensic Sciences

    Volume 51, Issue 1, January 2006, Pages: 179–182, Diana Garside, Jeri D. Ropero-Miller and Ellen C. Riemer

    Article first published online : 6 JAN 2006, DOI: 10.1111/j.1556-4029.2005.00021.x

  19. A Placebo-Controlled Trial of Atomoxetine in Marijuana-Dependent Individuals with Attention Deficit Hyperactivity Disorder

    The American Journal on Addictions

    Volume 19, Issue 6, November-December 2010, Pages: 481–489, Aimee L. McRae-Clark, Rickey E. Carter, Therese K. Killeen, Matthew J. Carpenter, Kathleen G. White and Kathleen T. Brady

    Article first published online : 21 SEP 2010, DOI: 10.1111/j.1521-0391.2010.00076.x

  20. Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 9, September 2013, Pages: 961–969, Ruth Cunill, Xavier Castells, Aurelio Tobias and Dolors Capellà

    Article first published online : 30 JUN 2013, DOI: 10.1002/pds.3473